Related Experiment Videos
Polysomies of chromosomes 7 and 17 in head and neck squamous cell carcinomas
1Department of Otolaryngology-Head and Neck Surgery, Korea University College of Medicine, Seoul.
Objective:
To determine the polysomies (ie, cells with > or = 3 chromosome copies) of chromosomes 7 and 17 in tumor tissue, histologically normal epithelia adjacent to the tumor (tumor-adjacent epithelia), and buccal epithelia distant from the tumor (tumor-distant epithelia) of head and neck squamous cell carcinomas.
Design:
Nonfluorescent, nonisotopic, in situ hybridization using chromosome-specific centromeric DNA probes for chromosomes 7 and 17 was performed on the formalin-fixed, paraffin-embedded specimens from tumor and tumor-adjacent and tumor-distant epithelia of 19 patients with head and neck squamous cell carcinomas and from buccal epithelia of cancer-free control subjects who smoked and did not smoke cigarettes.
Main Outcome Measures:
Four hundred nuclei in tumor tissue and 200 nuclei in histologically normal epithelia were scored for hybridized signals in each sample.
Results:
Buccal epithelia of cancer-free control subjects who smoked and did not smoke cigarettes showed no difference in the polysomies of chromosomes 7 and 17, respectively. The polysomies of chromosomes 7 and 17 in the tumor cells were higher than those in the tumor-adjacent epithelia (P < .001 for both), tumor-distant epithelia (P < .001 for both), and buccal epithelia of cancer-free control subjects who smoked and did not smoke cigarettes (P < .001 for both). The polysomies of chromosomes 7 and 17 in the tumor-adjacent epithelia were higher than those in the tumor-distant epithelia (P < .001 for both) and the control buccal epithelia (P = .002 and P < .001, respectively). The tumor-distant epithelia and the control buccal epithelia for the polysomies of chromosomes 7 and 17 had no differences.
Conclusions:
The finding of genotypic abnormalities in the tumor-adjacent epithelia supports the concept of field cancerization. Such genotypic parameters may provide a genetic basis for the development of an early recurrence or second primary tumors after therapeutic treatment of head and neck squamous cell carcinomas.